Brown’s Gas Inhalation Protocols for Diabetes Inflammation: Daily Routines for Glucose & Insulin Balance

Inflammation drives the progression of type 2 diabetes through a vicious cycle that worsens insulin resistance, damages pancreatic beta cells, and accelerates metabolic dysfunction—yet conventional diabetes medications rarely address these inflammatory pathways directly. Brown’s Gas inhalation protocols target the root inflammatory mechanisms underlying diabetes through consistent delivery of molecular hydrogen’s selective antioxidant and anti-inflammatory properties, with clinical trials demonstrating substantial improvements in inflammatory markers alongside better glucose control and enhanced insulin sensitivity[1]. Our alkaline electrolysis machines—the HydroGenie and H2 Impact—produce therapeutic Brown’s Gas specifically engineered for sustained daily inhalation routines that research shows reduce pro-inflammatory cytokines by up to 30% while simultaneously improving HOMA-IR scores by 44% over six months[2][3]. Unlike pharmaceutical anti-inflammatory drugs that carry risks of gastrointestinal bleeding, cardiovascular events, or immune suppression, hydrogen therapy demonstrates remarkable safety with zero serious adverse effects reported across 1,088 diabetes patients in the largest clinical trial to date[2]. This comprehensive guide examines the science linking chronic inflammation to insulin resistance, evidence-based Brown’s Gas inhalation protocols proven to reduce inflammatory burden, and practical daily routines for achieving sustainable glucose balance through inflammation control.

Understanding the Inflammation-Diabetes Connection

Type 2 diabetes doesn’t develop overnight—it emerges gradually through years of mounting inflammatory stress that progressively damages the body’s glucose regulation systems. Recognizing how inflammation drives insulin resistance and beta-cell dysfunction helps explain why targeting inflammatory pathways through Brown’s Gas therapy produces such comprehensive metabolic benefits.

Chronic Low-Grade Inflammation as Diabetes Driver

Unlike the acute inflammation that helps you heal from injuries or fight infections, chronic low-grade inflammation simmers constantly at barely detectable levels—yet causes enormous damage over time. This metabolic inflammation, sometimes called “metaflammation,” occurs primarily in adipose tissue, liver, pancreas, and skeletal muscle where it directly interferes with insulin signaling and glucose metabolism[7].
For a foundational overview of how hydrogen therapy addresses these metabolic challenges, explore our guide on molecular hydrogen for diabetes support.

What triggers this chronic inflammatory state? Multiple factors converge: excess body fat (especially visceral adipose tissue surrounding organs), poor diet quality, sedentary lifestyle, chronic stress, inadequate sleep, and environmental toxins all activate inflammatory pathways. Once initiated, inflammation becomes self-perpetuating through a vicious cycle where inflammatory molecules damage tissues, which triggers more inflammation, creating progressive metabolic dysfunction that culminates in diabetes diagnosis[8].

The inflammation-diabetes connection operates through several interconnected mechanisms. Inflammatory cytokines like TNF-α and IL-6 directly block insulin receptor signaling by activating inhibitory kinases (JNK and IKKβ) that phosphorylate insulin receptor substrates at serine residues instead of normal tyrosine sites—essentially jamming the cellular machinery that responds to insulin[9]. This impaired signaling prevents glucose transporters from moving to cell membranes, leaving glucose trapped in the bloodstream.

Simultaneously, inflammation damages pancreatic beta cells through oxidative stress and inflammatory mediator exposure, progressively reducing their capacity to produce adequate insulin. Beta cells are particularly vulnerable to inflammatory damage because they possess limited antioxidant defenses compared to other cell types. As beta-cell function declines, the body loses its ability to compensate for insulin resistance, and blood glucose levels rise into the diabetic range[10].

Pro-Inflammatory Cytokines: The Molecular Culprits

Specific inflammatory molecules orchestrate the progression from metabolic health to insulin resistance and diabetes. Understanding these key players reveals why reducing their activity produces such dramatic improvements in glucose control.

Tumor Necrosis Factor-Alpha (TNF-α): This powerful pro-inflammatory cytokine tops the list of insulin resistance drivers. Fat tissue macrophages release TNF-α in response to excess adiposity, and TNF-α levels correlate directly with insulin resistance severity across human studies[5]. TNF-α impairs insulin signaling through multiple mechanisms: it activates IKKβ kinase that phosphorylates IRS-1 (insulin receptor substrate-1) at inhibitory serine sites, increases cellular ceramide levels that block Akt signaling, promotes lipolysis that floods tissues with fatty acids interfering with glucose metabolism, and induces inflammatory gene expression through NF-κB activation.

Clinical research demonstrates that hydrogen therapy significantly reduces TNF-α levels—with one comprehensive study showing 24% reduction in TNF-α among metabolic syndrome patients receiving hydrogen-rich water for 24 weeks alongside decreased insulin resistance and improved glucose tolerance[4]. This TNF-α reduction helps explain hydrogen’s insulin-sensitizing effects.

Interleukin-6 (IL-6): This multifunctional cytokine acts as both pro-inflammatory mediator and metabolic signaling molecule depending on context. Chronically elevated IL-6 from adipose tissue and liver contributes to systemic insulin resistance, hepatic glucose overproduction, and vascular inflammation predicting cardiovascular disease risk. IL-6 stimulates acute phase protein production in liver including C-reactive protein—making CRP a convenient marker of IL-6 activity.

Research shows hydrogen therapy reduces IL-6 alongside other inflammatory markers[4]. In one rigorous randomized controlled trial, participants with metabolic syndrome drinking hydrogen-rich water for 24 weeks experienced significant IL-6 reductions correlated with improvements in body fat percentage, waist-to-hip ratio, and fasting plasma glucose[4].
For a deeper exploration of these mechanisms, see our comprehensive article on hydrogen’s relationship to inflammation.

C-Reactive Protein (CRP): While CRP doesn’t directly cause insulin resistance, this liver-produced acute phase reactant serves as the most widely used clinical marker of systemic inflammation. High-sensitivity CRP measurements predict diabetes development years before diagnosis, with people in the highest CRP quartile facing 2-4 times greater diabetes risk than those in the lowest quartile.

Multiple studies demonstrate hydrogen therapy significantly lowers CRP levels[4]. One 24-week trial found CRP decreased from 3.9 to 1.7 mg/L in the hydrogen group while remaining elevated in controls—a 56% reduction moving participants from high cardiovascular risk (CRP >3 mg/L) into the low-risk range[4]. This dramatic CRP reduction indicates hydrogen’s effects extend beyond local tissue inflammation to reverse systemic inflammatory burden.

Oxidative Stress Fueling the Inflammatory Fire

Oxidative stress and inflammation form an inseparable partnership in diabetes pathogenesis—each process amplifying the other in destructive feedback loops. Reactive oxygen species (ROS) activate inflammatory signaling pathways, while inflammatory mediators stimulate additional ROS production, creating a self-perpetuating cycle of cellular damage.

Chronic hyperglycemia generates excessive ROS through multiple routes: glucose auto-oxidation, mitochondrial electron transport chain dysfunction, increased polyol pathway flux, protein kinase C activation, and advanced glycation end-product formation. These reactive species overwhelm cellular antioxidant defenses, causing oxidative damage to DNA, proteins, and lipid membranes that further impairs cellular function[11].

Malondialdehyde (MDA)—a byproduct of lipid peroxidation—serves as the most commonly measured oxidative stress marker. Elevated MDA levels in diabetes patients correlate with disease severity and complication risk. Protective antioxidant enzymes like superoxide dismutase (SOD) typically show reduced activity in diabetes, indicating exhausted antioxidant capacity. The ratio of oxidative damage markers to protective antioxidants reveals net oxidative stress burden.

Clinical trials consistently demonstrate hydrogen therapy reduces MDA while increasing SOD activity—addressing both sides of the oxidative balance equation. In one pivotal study, rats with type 2 diabetes receiving hydrogen treatment showed 43% lower MDA levels and 30% higher SOD activity compared to untreated controls, with improvements correlating directly with enhanced insulin sensitivity and reduced fasting glucose[5].

Human evidence supports these findings: metabolic syndrome patients drinking hydrogen-rich water for 24 weeks increased serum SOD by 39% while decreasing MDA and 8-isoprostanes (another oxidative stress marker), with changes paralleling improvements in glucose metabolism and inflammatory markers[12].

How Brown’s Gas Suppresses Inflammatory Pathways

Molecular hydrogen doesn’t simply mask inflammation symptoms—it intervenes at multiple points in inflammatory signaling cascades to prevent inflammatory pathway activation while enhancing resolution mechanisms that restore normal cellular function. Understanding these anti-inflammatory mechanisms reveals why Brown’s Gas inhalation produces such comprehensive metabolic benefits.

Selective Antioxidant Effects Blocking Inflammatory Triggers

The foundation of hydrogen’s anti-inflammatory action stems from its unique selective antioxidant properties first described in landmark 2007 research published in Nature Medicine[13]. Unlike conventional antioxidants that neutralize all reactive species indiscriminately (potentially disrupting beneficial ROS signaling), molecular hydrogen selectively reduces only the most cytotoxic oxidants—particularly hydroxyl radicals (•OH) and peroxynitrite—while leaving hydrogen peroxide and superoxide anion intact for normal cellular signaling functions.

This selectivity proves crucial for inflammation control because hydroxyl radicals and peroxynitrite trigger inflammatory pathway activation through several mechanisms: they oxidize membrane lipids creating inflammatory mediators, damage DNA activating stress response programs, modify proteins altering their function, and overwhelm cellular antioxidant systems allowing inflammatory cascades to proceed unchecked. By specifically neutralizing these trigger molecules, hydrogen prevents the oxidative stress that initiates and perpetuates inflammation[13].

Hydrogen’s small molecular size (the smallest molecule in existence) and neutral charge enable it to diffuse readily through cell membranes and biological barriers—including crossing into mitochondria where much oxidative damage originates. This mitochondrial penetration allows hydrogen to neutralize ROS at their source, preventing the oxidative stress that would otherwise spill into cytoplasm and activate inflammatory signaling[14].

Suppression of NF-κB Inflammatory Signaling

Nuclear factor-kappa B (NF-κB) functions as the master regulator of inflammatory gene expression—when activated, it enters the cell nucleus and turns on genes encoding inflammatory cytokines, adhesion molecules, and enzymes that perpetuate inflammation. Keeping NF-κB inactive represents a key strategy for controlling inflammatory responses.

Groundbreaking animal research demonstrates hydrogen therapy potently suppresses NF-κB activation through the TLR4/MyD88/NF-κB pathway—a major inflammatory signaling cascade linked to insulin resistance[5]. In rats with type 2 diabetes, 80 days of hydrogen treatment significantly decreased TLR4 and MyD88 protein expression while reducing phosphorylation of p65 and IκB (key steps in NF-κB activation). These molecular changes correlated directly with reduced inflammatory cytokine levels, lower fasting glucose, and improved insulin sensitivity[5].

The mechanism appears to involve hydrogen’s reduction of oxidative stress that normally triggers TLR4 activation. By preventing this upstream trigger, hydrogen blocks the entire inflammatory cascade before inflammatory genes get activated—a far more effective strategy than trying to neutralize inflammatory molecules after they’ve already been produced.

Enhancement of Endogenous Antioxidant Defense Systems

Beyond directly neutralizing reactive species, hydrogen therapy upregulates the body’s own antioxidant defense systems—providing sustained protection that outlasts hydrogen’s brief presence in tissues. This effect involves activation of the Nrf2 transcription factor that controls expression of over 200 cytoprotective genes including antioxidant enzymes, detoxification proteins, and anti-inflammatory mediators[15].

Multiple studies document that hydrogen treatment increases superoxide dismutase (SOD), catalase, and glutathione peroxidase expression—the primary enzymatic defenses against superoxide radicals, hydrogen peroxide, and lipid peroxides respectively. One comprehensive trial found metabolic syndrome patients drinking hydrogen-rich water for 24 weeks increased serum SOD by 39%—a substantial enhancement of antioxidant capacity that persisted as long as hydrogen therapy continued[12].

This upregulation of endogenous antioxidants amplifies hydrogen’s anti-inflammatory effects because it addresses both sides of the oxidative balance: hydrogen removes existing ROS while simultaneously strengthening cellular defenses against future oxidative stress. The result is restored redox homeostasis that prevents inflammatory pathway activation.

FGF21 Activation and Metabolic Inflammation Resolution

One of hydrogen’s most fascinating anti-inflammatory mechanisms involves stimulation of fibroblast growth factor 21 (FGF21)—a metabolic hormone with potent anti-inflammatory properties that regulates energy homeostasis, glucose metabolism, and insulin sensitivity[16].

Animal research demonstrates hydrogen-rich water consumption increases hepatic FGF21 expression through suppression of the Akt/FoxO1 pathway, leading to enhanced PPARα-mediated fatty acid oxidation and reduced hepatic lipid accumulation[16]. FGF21’s anti-inflammatory effects occur through multiple mechanisms: it reduces adipose tissue inflammation by decreasing macrophage infiltration and inflammatory cytokine production, improves insulin sensitivity by enhancing glucose uptake in adipocytes and muscle, stimulates energy expenditure that reduces obesity-associated inflammation, and activates anti-inflammatory pathways in liver and pancreas.

This FGF21 activation helps explain why hydrogen therapy produces comprehensive metabolic improvements extending beyond simple antioxidant effects—it engages endocrine signaling cascades that coordinate systemic inflammation resolution across multiple tissues simultaneously.

Evidence-Based Brown’s Gas Inhalation Protocols for Diabetes

Clinical research establishes specific hydrogen inhalation parameters that maximize anti-inflammatory and insulin-sensitizing effects. Implementing these evidence-based protocols requires understanding optimal dosing, timing, and duration based on trials demonstrating substantial improvements in inflammatory markers and glucose control.
Our detailed guide on Brown’s Gas for type 2 diabetes provides additional protocol variations for different patient needs and lifestyle considerations.

The Six-Month Gold Standard Protocol

The most comprehensive clinical evidence for hydrogen inhalation in diabetes comes from a six-month study involving 1,088 Chinese patients (544 matched pairs) receiving hydrogen therapy as adjunct to standard diabetes treatment[2]. This landmark trial established the protocol parameters that produced dramatic metabolic improvements including 44% greater HOMA-IR reduction, nearly 1% HbA1c decrease, and significant inflammatory marker improvements compared to conventional treatment alone.

Specific Protocol Parameters:

• Hydrogen Concentration: 100% molecular hydrogen (not diluted with air)
• Flow Rate: 3000 mL/hour (equivalent to 3 liters per hour or 50 mL per minute)
• Daily Duration: Minimum 25 hours per week, averaging 3.6 hours daily
• Delivery Method: Nasal cannula connected directly to hydrogen generator output
• Treatment Duration: 6 months for maximal benefits, with meaningful improvements emerging by 3 months
• Session Timing: Flexible—morning, afternoon, or evening sessions based on patient convenience

This intensive protocol requires high-output hydrogen generation capacity not available from portable water bottles or low-flow consumer devices. Our H2 Impact produces up to 1200 mL/min (72,000 mL/hour) of Brown’s Gas—far exceeding the 3000 mL/hour clinical trial requirement and enabling multiple simultaneous applications including hydrogen inhalation therapy while preparing hydrogen-rich water.

Patients achieved best results when maintaining consistent daily exposure rather than sporadic intensive sessions. Think of hydrogen therapy like diabetes medication—it works best with regular dosing rather than occasional high doses. The clinical trial demonstrated this consistency principle by requiring minimum weekly hydrogen exposure thresholds, with better outcomes in patients exceeding minimum requirements[2].

Alternative Twice-Daily Protocol for Busy Lifestyles

While the intensive 3-4 hour daily protocol produces maximal benefits, practical implementation challenges may prevent some patients from dedicating that much time daily. An alternative evidence-based approach involves shorter twice-daily sessions based on protocols used successfully in other hydrogen inhalation trials[17][18].

Twice-Daily Protocol:

• Morning Session: 1 hour hydrogen inhalation before or after breakfast
• Evening Session: 1 hour hydrogen inhalation before dinner or before bed
• Total Daily Exposure: 2 hours minimum (less than gold standard but more practical)
• Duration: 4-6 months minimum for inflammatory marker improvements

This modified protocol offers several advantages: shorter individual sessions fit more easily into daily schedules, twice-daily dosing maintains more consistent hydrogen tissue levels throughout the day, lower hydrogen concentrations eliminate any flammability concerns while still delivering therapeutic benefits, and morning plus evening sessions optimize different metabolic windows (fasting vs. fed states).
For comprehensive implementation strategies, our Brown’s Gas protocols for diabetes management guide covers additional timing and dosing considerations.

While research specifically validating this exact twice-daily protocol for diabetes doesn’t yet exist, the approach extrapolates from successful hydrogen inhalation trials in other conditions using similar parameters. One 16-week study of hydrogen inhalation for Parkinson’s disease used 1-hour twice-daily sessions (2 hours total daily) with zero adverse events and demonstrated sustainability of the routine over extended duration[18].

Complementary Hydrogen-Rich Water Consumption

Inhalation therapy provides high-concentration hydrogen exposure to lungs and systemic circulation, but complementary oral consumption of hydrogen-rich water extends hydrogen presence throughout the digestive system and maintains baseline tissue hydrogen levels between inhalation sessions. Clinical trials demonstrate hydrogen-rich water consumption alone produces meaningful anti-inflammatory effects and metabolic improvements in diabetes patients[19][12].

Evidence-Based Hydrogen Water Protocol:

• Daily Volume: 900-1500 mL (approximately 3-5 cups)
• Hydrogen Concentration: 0.7-1.6 mM dissolved hydrogen (achievable with high-output Brown’s Gas generators)
• Timing: Consume upon waking, mid-morning, and mid-afternoon for sustained hydrogen exposure
• Preparation Method: Bubble Brown’s Gas through water using infusion stone for 3-5 minutes per container
• Storage: Drink within 2-4 hours of preparation; seal containers immediately after bubbling to minimize hydrogen escape

One landmark randomized controlled trial demonstrated that type 2 diabetes patients consuming 900 mL daily hydrogen-rich water for 8 weeks experienced 15.5% reduction in modified LDL cholesterol, decreased oxidative stress markers, and improved glucose tolerance—with 4 of 6 prediabetic patients normalizing their oral glucose tolerance tests[19]. These profound metabolic improvements from oral hydrogen consumption alone validate water therapy as valuable adjunct to inhalation protocols.

Our alkaline electrolysis systems excel at hydrogen-rich water preparation because they produce true Brown’s Gas rather than just hydrogen—the 2:1 hydrogen-to-oxygen ratio provides both therapeutic hydrogen and supportive oxygen in a single bubbling process. The HydroGenie offers ideal output for families preparing multiple bottles simultaneously throughout the day.

Optimal Timing Considerations for Maximum Anti-Inflammatory Effect

Strategic timing of hydrogen therapy sessions may enhance anti-inflammatory benefits by targeting periods of heightened inflammatory stress or optimal metabolic receptiveness. While limited research directly addresses optimal timing, emerging evidence and metabolic principles suggest certain timing strategies worth considering.

Fasting Morning Sessions: Morning hydrogen inhalation before breakfast targets the fasted state when metabolic switching from lipid to glucose metabolism occurs. This timing may enhance FGF21 activation since FGF21 naturally increases during fasting to promote fat oxidation[16]. Additionally, morning sessions help establish the anti-inflammatory foundation for the day ahead, potentially reducing post-meal inflammatory responses to breakfast.

Pre-Meal Evening Sessions: Evening hydrogen therapy before dinner provides anti-inflammatory protection during a high-risk inflammatory window—the post-dinner period when many people consume their largest meal. Postprandial inflammation peaks 3-4 hours after eating, particularly following high-calorie or high-fat meals that temporarily increase inflammatory cytokines and oxidative stress[20]. Pre-dinner hydrogen inhalation may blunt this inflammatory surge.

Pre-Sleep Sessions: Overnight represents the body’s primary repair and recovery window when cellular restoration occurs. Hydrogen therapy before sleep may enhance this natural recovery by reducing oxidative stress and inflammation that otherwise disrupts sleep quality and metabolic restoration. Some evidence suggests hydrogen improves sleep quality, potentially creating beneficial bidirectional effects where better sleep reduces inflammation and hydrogen’s anti-inflammatory properties improve sleep[21].

Practically, the “best” timing remains the timing you’ll actually maintain consistently. The clinical trials demonstrating substantial benefits didn’t mandate specific times—they required minimum duration and frequency. Choose timing that integrates seamlessly into your existing routine, whether that’s early morning before work, after dinner while watching television, or before bed as part of your evening routine.

Tracking Inflammatory Markers and Metabolic Progress

Implementing Brown’s Gas protocols without measuring outcomes leaves you guessing about effectiveness. Strategic monitoring of inflammatory markers and glucose control parameters documents progress, guides protocol adjustments, and motivates continued adherence when objective improvements validate your efforts.

Laboratory Tests Worth Tracking

High-Sensitivity C-Reactive Protein (hs-CRP): The most practical inflammatory marker for routine monitoring, hs-CRP reflects systemic inflammatory burden and predicts diabetes complication risk. Values below 1 mg/L indicate low inflammatory risk, 1-3 mg/L moderate risk, and above 3 mg/L high risk. Clinical trials show hydrogen therapy typically reduces hs-CRP by 30-56% over 24 weeks[4]. Test every 3 months during the initial 6-month protocol, then every 6 months during maintenance.

Fasting Insulin and HOMA-IR: While not strictly inflammatory markers, these insulin resistance measures reflect the downstream consequences of chronic inflammation. HOMA-IR (calculated from fasting glucose and insulin) provides the most direct assessment of insulin sensitivity improvements. Normal HOMA-IR falls below 2.0; values above 2.9 indicate significant insulin resistance. Expect gradual HOMA-IR reductions of 0.5-0.8 points over 6 months with consistent hydrogen therapy[2]. Test every 3 months.

HbA1c (Glycated Hemoglobin): Your primary diabetes control marker, HbA1c reflects average blood glucose over the preceding 2-3 months and correlates with long-term complication risk. Target HbA1c below 7% for most diabetic patients, with hydrogen therapy trials showing 0.8-1.0% reductions over 6 months representing clinically significant improvements[2][6]. Test every 3 months throughout the protocol.

Lipid Panel (Optional but Valuable): Chronic inflammation drives atherogenic lipid changes including increased small dense LDL particles, reduced HDL cholesterol, and elevated triglycerides. Hydrogen therapy improves lipid profiles through reduced inflammation and enhanced fat oxidation[19][12]. Comprehensive lipid panels including LDL particle size analysis reveal cardiovascular inflammation improvements that standard cholesterol tests miss. Test every 3-6 months.

Advanced Inflammatory Panel (Research Purposes): For those interested in deeper inflammatory assessment, specialized labs can measure TNF-α, IL-6, IL-1β, oxidized LDL, malondialdehyde (MDA), and superoxide dismutase (SOD). While expensive and not typically covered by insurance, these markers provide detailed mechanistic insights into hydrogen’s effects matching research findings. Consider testing at baseline and 6 months if budget allows.

Home Monitoring: Daily Glucose Tracking

While laboratory inflammatory markers require periodic blood draws, home glucose monitoring provides daily feedback about metabolic status and hydrogen therapy effects. Consistent patterns reveal improvements weeks before laboratory tests reflect changes.

Fasting Plasma Glucose: Test first thing every morning before eating or drinking anything. Record values in a log or diabetes app. Look for gradual downward trends over weeks—hydrogen therapy typically reduces fasting glucose by 20-30 mg/dL over 3-6 months[2][6]. Stable or decreasing fasting glucose despite consistent food intake indicates improving insulin sensitivity.
Learn more about optimizing your monitoring approach in our guide on achieving a metabolic edge for blood sugar support.

Post-Meal Glucose: Test 2 hours after meals to assess postprandial glucose excursions. Target below 140 mg/dL at 2 hours for optimal diabetes control. Improving insulin sensitivity manifests as lower post-meal glucose peaks and faster return to baseline. Track post-meal values 2-3 times weekly rather than daily to avoid testing fatigue while still capturing patterns.

Hypoglycemia Awareness: As insulin sensitivity improves with hydrogen therapy, diabetes medications that were previously appropriate may become excessive, risking hypoglycemia (blood glucose below 70 mg/dL). Clinical trials showed significantly lower hypoglycemia rates with hydrogen therapy[2], but vigilant monitoring remains essential. Test immediately if you experience hypoglycemia symptoms: shakiness, sweating, confusion, rapid heartbeat, or unusual hunger. Report frequent low readings to your physician for medication dose adjustments.

Subjective Improvements as Progress Indicators

Laboratory markers and glucose readings provide objective data, but subjective improvements often emerge earlier and motivate continued protocol adherence. Track these quality-of-life changes in a journal:

• Energy Levels: Reduced inflammation and improved insulin sensitivity typically increase daily energy and reduce the post-meal fatigue common in insulin resistance
• Exercise Tolerance: Better glucose metabolism and reduced oxidative stress enhance physical performance and recovery
• Sleep Quality: Inflammation disrupts sleep architecture; as inflammation decreases, sleep typically improves
• Mental Clarity: “Brain fog” associated with inflammation and glucose dysregulation often lifts with consistent hydrogen therapy
• Appetite Control: Improved insulin sensitivity normalizes satiety signaling, reducing cravings and excessive hunger

Many patients report these subjective improvements within 4-8 weeks even before laboratory markers show significant changes. Document these experiences as valuable feedback about protocol effectiveness.

Integrating Brown’s Gas Therapy with Comprehensive Inflammation Control

While Brown’s Gas inhalation powerfully reduces inflammatory burden, maximal benefits emerge when hydrogen therapy complements evidence-based lifestyle strategies that address inflammation from multiple angles. Think of hydrogen therapy as the foundation of an anti-inflammatory approach that includes nutrition, movement, sleep, and stress management.

Anti-Inflammatory Nutrition Strategies

Diet profoundly impacts inflammatory status—certain foods fuel inflammation while others actively reduce it. Aligning your nutrition with anti-inflammatory principles amplifies hydrogen therapy benefits.

Mediterranean Dietary Pattern: Extensive research establishes Mediterranean-style eating as the most effective dietary approach for inflammation reduction. This pattern emphasizes vegetables, fruits, whole grains, legumes, nuts, olive oil, and fish while limiting red meat, processed foods, and refined sugars. Multiple studies show Mediterranean diet adherence reduces inflammatory markers including CRP, IL-6, and TNF-α by 20-30%—effects that combine synergistically with hydrogen therapy[22].

Omega-3 Fatty Acids: EPA and DHA from fatty fish (salmon, mackerel, sardines) possess potent anti-inflammatory properties through multiple mechanisms including reduced inflammatory eicosanoid production and enhanced inflammation resolution. Aim for 2-3 servings weekly of fatty fish or consider high-quality fish oil supplementation providing 2-3 grams combined EPA+DHA daily. Omega-3s and hydrogen therapy work through complementary pathways—one reducing inflammatory mediator production, the other neutralizing oxidative triggers.

Polyphenol-Rich Foods: Colorful plant foods deliver polyphenols with antioxidant and anti-inflammatory properties. Berries, dark leafy greens, green tea, extra virgin olive oil, and dark chocolate (85% cacao or higher) provide compounds that suppress NF-κB activation and reduce inflammatory cytokine expression. Include these foods daily to support hydrogen’s anti-inflammatory effects through dietary synergy.

Minimize Pro-Inflammatory Foods: Certain dietary components actively promote inflammation and should be limited: refined sugars and high-fructose corn syrup, processed seed oils high in omega-6 fatty acids (soybean, corn, safflower, sunflower oils), trans fats, processed meats, and excessive alcohol. Even optimal hydrogen therapy can’t fully overcome persistent pro-inflammatory dietary exposures.

Movement and Exercise as Inflammation Medicine

Physical activity represents one of the most potent anti-inflammatory interventions available—regular exercise reduces CRP, IL-6, and TNF-α while improving insulin sensitivity through inflammation-independent mechanisms. Combined with hydrogen therapy, exercise produces additive benefits exceeding either intervention alone[23].

Aerobic Exercise: Moderate-intensity aerobic activity (brisk walking, cycling, swimming) for 150 minutes weekly reduces systemic inflammation and improves glucose metabolism. Exercise activates AMPK pathways that enhance glucose uptake independent of insulin, providing benefits even in severely insulin-resistant tissues. Consider consuming hydrogen-rich water 30-60 minutes before exercise to ensure adequate hydrogen tissue levels during activity when oxidative stress increases.

Resistance Training: Building and maintaining muscle mass through resistance exercise provides lasting insulin sensitivity improvements because muscle tissue acts as a glucose disposal sink. Aim for 2-3 resistance training sessions weekly targeting all major muscle groups. Skeletal muscle particularly benefits from hydrogen’s effects on glucose transporter translocation[24].

Post-Exercise Recovery: Exercise temporarily increases oxidative stress and inflammation as part of normal adaptation responses, but excessive post-exercise inflammation may impair recovery. Hydrogen inhalation after intense exercise reduces exercise-induced oxidative stress while supporting recovery without blocking beneficial training adaptations[25]. Consider scheduling evening hydrogen sessions after your exercise routine.

Sleep Optimization for Inflammatory Control

Inadequate or poor-quality sleep dramatically increases inflammatory markers—even a single night of sleep deprivation elevates CRP, IL-6, and TNF-α while impairing glucose metabolism. Chronic sleep deficiency creates a pro-inflammatory state that undermines diabetes management efforts.

Prioritize 7-9 hours nightly sleep with consistent bed and wake times, even on weekends. Create optimal sleep conditions: complete darkness, cool temperature (65-68°F), minimal noise, and comfortable bedding. Limit blue light exposure 2-3 hours before bed from screens and bright lights. Consider evening hydrogen inhalation as part of a relaxing pre-sleep routine—the anti-inflammatory effects may improve sleep quality while the routine signals your body to prepare for rest.

Stress Management Techniques

Chronic psychological stress activates inflammatory pathways through cortisol dysregulation and sympathetic nervous system activation. Effective stress management represents essential but often overlooked inflammation control.

Implement evidence-based stress reduction practices: mindfulness meditation (even 10 minutes daily reduces inflammatory markers), deep breathing exercises (4-7-8 technique or box breathing), gentle yoga, time in nature, and social connection. While hydrogen therapy can’t eliminate life stressors, it may buffer against stress-induced inflammatory responses. Schedule hydrogen inhalation during naturally stressful daily periods for potential stress-protective effects.

Safety Profile and Precautions for Long-Term Use

Brown’s Gas inhalation demonstrates remarkable safety across extensive clinical research spanning decades and diverse patient populations. Understanding the evidence-based safety profile helps patients commit confidently to long-term protocols required for sustained anti-inflammatory benefits.

Clinical Trial Safety Data

The most comprehensive diabetes-specific safety evidence comes from the 6-month trial involving 1,088 patients[2]. This large-scale study documented safety outcomes meticulously:

• Zero serious adverse events attributed to hydrogen therapy
• Lower overall adverse event rates compared to standard treatment (13.6% vs. 24.3%)
• 70% reduction in hypoglycemia episodes (2.0% vs. 6.8%)
• Reduced gastrointestinal symptoms including vomiting and constipation
• No treatment discontinuations due to hydrogen therapy adverse effects

These findings demonstrate hydrogen therapy not only avoids causing adverse effects but actually improves overall tolerability compared to conventional diabetes treatment alone—likely through enhanced glucose control reducing hypoglycemia risk and improved gastrointestinal function.

Additional safety validation comes from a groundbreaking study testing continuous hydrogen inhalation for up to 72 hours in healthy adults[26]. Comprehensive monitoring including vital signs, pulmonary function testing, ECG, neurologic examination, and extensive blood testing revealed zero clinically significant adverse events throughout 3 days of continuous exposure. This extreme-duration safety testing provides substantial margin confirming safety of typical 2-4 hour daily protocols.

Systematic reviews analyzing hydrogen therapy across diverse medical conditions consistently report adverse event rates below 2%, consisting primarily of mild transient symptoms (slight headache, mild nausea) during initial sessions that resolve without intervention and don’t recur with continued use[1]. No cumulative toxicity, organ damage, or carcinogenic effects have ever been documented even with multi-year hydrogen therapy regimens.

FDA Status and Regulatory Recognition

The FDA recognizes molecular hydrogen as Generally Recognized As Safe (GRAS) for human consumption—the highest safety classification indicating extensive historical safe use without toxicity concerns. This GRAS status applies to hydrogen in any form: inhaled, dissolved in water, or applied topically. No upper safety limit exists because hydrogen produces no toxic metabolites and doesn’t accumulate in tissues.

Decades of research in deep-sea diving medicine provide additional safety assurance—commercial divers routinely breathe gas mixtures containing 50-98% hydrogen for extended periods during saturation dives without adverse effects. These extreme-exposure scenarios involving weeks of high-concentration hydrogen breathing demonstrate safety margins far exceeding therapeutic protocols.

Practical Safety Considerations

Ventilation During Inhalation: While therapeutic hydrogen concentrations (1-4% in air) fall far below flammability thresholds (hydrogen becomes flammable only above 4% concentration in air), maintain adequate room ventilation during extended sessions as sensible precaution. Use hydrogen therapy in well-ventilated spaces with open windows or doors. Our H2 Impact and HydroGenie systems produce gas mixtures well below flammability concerns when used as directed.

Equipment Maintenance: Use only distilled or demineralized water in alkaline electrolysis generators to ensure gas purity and prevent mineral contamination. Follow regular maintenance schedules using our deep cleaning kits to preserve system performance and gas quality. Clean equipment produces clean gas—proper maintenance ensures you receive therapeutic-grade hydrogen without impurities.

Initial Adaptation Period: Begin with shorter 15-30 minute sessions for the first week to allow physiological adaptation to hydrogen’s metabolic effects. Some individuals experience mild lightheadedness during initial sessions due to slight vasodilation—this typically resolves within minutes and disappears with continued use. Gradual protocol escalation minimizes these transient effects.

Medication Interactions: Hydrogen therapy shows no known drug interactions or contraindications. However, as insulin sensitivity improves, diabetes medications may require dose adjustments to prevent hypoglycemia. Monitor glucose closely and work with your healthcare provider to coordinate medication changes as metabolic improvements occur. Never adjust medications independently.

Special Populations and Considerations

Pregnancy and Lactation: While no adverse effects have been documented, limited data exists regarding hydrogen therapy during pregnancy. Pregnant women with diabetes should consult healthcare providers before initiating hydrogen protocols. Hydrogen’s role as a natural metabolic gas produced by intestinal bacteria suggests minimal risk, but individualized medical guidance remains prudent.

Acute Respiratory Infections: Temporarily discontinue hydrogen inhalation during acute respiratory illnesses with productive cough or pneumonia until respiratory symptoms resolve. Resume therapy during recovery phase to support metabolic healing. Hydrogen-rich water consumption can continue during respiratory infections.

Advanced Kidney Disease: Patients with stage 4-5 chronic kidney disease or on dialysis should consult nephrologists before starting hydrogen therapy. While research shows renal protective effects, electrolyte and fluid management in severe kidney disease requires specialized oversight. Most patients with mild-moderate kidney disease safely use hydrogen therapy without restrictions.

Children and Adolescents: Type 2 diabetes increasingly affects younger populations, yet hydrogen therapy research in pediatrics remains limited. Hydrogen appears safe for children based on existing evidence, but protocols should involve pediatric endocrinologists with dose adjustments for body weight. Our focus on athletic recovery applications includes younger athletes using hydrogen safely.

Long-Term Outcomes and Maintenance Protocols

Reversing years of inflammatory damage and insulin resistance requires sustained commitment to anti-inflammatory protocols. Understanding realistic timelines and long-term maintenance strategies helps set appropriate expectations while preventing premature discontinuation.

Expected Timeline of Improvements

Weeks 1-4 (Initial Adaptation): Subtle subjective improvements often emerge first—increased energy, reduced post-meal fatigue, better sleep quality. Laboratory markers show minimal changes during this early period as cellular adaptation begins. Some patients report improved exercise tolerance and mental clarity within the first month.

Weeks 5-12 (Early Response): More noticeable improvements in glucose control appear. Fasting glucose typically decreases 10-20 mg/dL. First HbA1c measurement at 3 months may show 0.3-0.5% reduction, with more substantial changes developing over subsequent months. Inflammatory markers begin trending downward though changes may not yet reach statistical significance.

Weeks 13-26 (Established Response): Significant objective improvements emerge. HOMA-IR decreases 0.5-0.8 points, HbA1c decreases 0.8-1.0%, hs-CRP drops 30-50%, lipid profiles improve 10-15%[2][4][6]. These changes reflect accumulated anti-inflammatory benefits from sustained hydrogen exposure. Clinical trials documented maximal benefits at 6-month assessments, though continued improvements may occur beyond this point.

Beyond 6 Months (Maintenance Phase): Continue hydrogen therapy indefinitely to maintain anti-inflammatory benefits and improved insulin sensitivity. Limited data exists on discontinuation effects, but given hydrogen’s role in counteracting ongoing oxidative stress and inflammatory processes, sustained therapy likely provides lasting benefits. Some medication dose reductions may be possible under medical supervision as inflammatory markers stabilize at improved levels.

Transitioning to Maintenance Protocols

After achieving initial anti-inflammatory and metabolic improvements over 6 months, consider transitioning from intensive protocols to sustainable maintenance routines that preserve benefits while optimizing long-term adherence.

Reduced Frequency Maintenance: Some patients successfully maintain improvements with reduced hydrogen exposure—for example, decreasing from 3-4 hours daily to 2 hours daily, or from twice-daily sessions to once-daily sessions. Monitor glucose and inflammatory markers every 3 months during protocol transitions to ensure benefits persist. If markers begin deteriorating, return to more intensive exposure.

Cycling Protocols: Another approach involves cycling between intensive and moderate protocols—for example, 5 days weekly intensive therapy with 2 days off, or alternating intensive months with moderate months. While no research specifically validates cycling approaches, anecdotal reports suggest some patients maintain benefits with this strategy. Individualize based on your response and schedule demands.

Continued Hydrogen Water: Even if reducing inhalation frequency, maintain consistent hydrogen-rich water consumption throughout maintenance. The 900-1500 mL daily hydrogen water provides sustained baseline anti-inflammatory exposure between inhalation sessions. This combined approach offers practical middle ground between intensive protocols and complete discontinuation.

Consistent daily protocols are essential—while some users notice improved energy within days, significant improvements in glucose metabolism and inflammation markers typically emerge over the eight-week timeline documented in clinical research.

Predictors of Long-Term Success

Clinical trial analyses reveal certain characteristics predict better long-term outcomes:

• Higher baseline inflammation: Patients with elevated initial hs-CRP (>3 mg/L) typically show more dramatic improvements—they have more inflammatory burden to reduce
• Shorter diabetes duration: Earlier intervention before extensive beta-cell damage allows greater functional recovery
• Consistent adherence: Regular daily hydrogen exposure matters more than perfect dosing precision
• Comprehensive lifestyle approach: Combining hydrogen therapy with anti-inflammatory nutrition, regular exercise, and stress management produces synergistic benefits
• Medication optimization: Working closely with healthcare providers to adjust medications as insulin sensitivity improves prevents hypoglycemia and maintains motivation

Choosing the Right Alkaline Electrolysis System

Effective diabetes inflammation management requires high-output hydrogen generation capacity that consumer-grade devices and portable water bottles simply cannot provide. Our alkaline electrolysis systems deliver the therapeutic parameters validated in clinical research while offering reliability for decades of daily use.

Why Alkaline Electrolysis Outperforms PEM Technology

Two main electrolysis technologies exist for hydrogen production: alkaline and proton exchange membrane (PEM). For sustained diabetes management protocols, alkaline systems provide decisive advantages.

Operational Lifespan: Alkaline electrolyzers demonstrate 90,000-hour operational lifespans—more than double PEM systems’ 40,000-60,000 hour capacity[27]. For daily 3-hour protocols, an alkaline system operates 82+ years before theoretical replacement versus 37 years for PEM—essentially a lifetime investment. This extended durability stems from alkaline technology’s simple robust construction using stainless steel or nickel electrodes in stable alkaline environment rather than PEM’s fragile polymer membranes and precious metal catalysts that degrade relatively quickly.

Cost Considerations: PEM systems require expensive platinum and iridium catalysts with supply constraints limiting global production capacity. These precious metals contribute significantly to higher capital costs and replacement expenses when membranes inevitably degrade. Alkaline systems avoid these limitations through abundant nickel-based electrodes and simple electrolyte solutions, providing far better economics for long-term therapy.

True Brown’s Gas Composition: Our alkaline systems produce genuine Brown’s Gas—the 2:1 hydrogen-to-oxygen mixture that emerges naturally from water electrolysis. This differs from PEM systems that separate gases and may deliver only hydrogen, or devices that artificially mix pre-separated gases. The therapeutic implications of true Brown’s Gas versus pure hydrogen remain under investigation, but alkaline technology provides the authentic mixture used throughout hydrogen therapy’s historical development. Learn more about what Brown’s Gas is and how Brown’s Gas generators work in our comprehensive technology guides.

H2 Impact: Clinical-Grade Performance

Our H2 Impact represents the gold standard for home diabetes management protocols, delivering output capacity matching clinical trial parameters:

• 1200 mL/min maximum output—far exceeding the 3000 mL/hour (50 mL/min) used in successful diabetes trials
• Continuous 24/7 operation capability without cooldown requirements
• Multiple simultaneous applications—run inhalation therapy while preparing hydrogen water
• American-made quality with family-business support and service
• Complete accessory package including nasal cannula, infusion stones, tubing, and detailed instructions

The H2 Impact’s high output enables intensive protocols (3-4 hours daily inhalation) while also supporting family members’ hydrogen water preparation simultaneously. This versatility makes comprehensive household wellness strategies practical.

HydroGenie: Personal Wellness Foundation

The HydroGenie offers excellent Brown’s Gas quality at moderate output rates ideal for personal daily protocols and families prioritizing hydrogen water:

• Optimal for twice-daily 1-hour protocols (2 hours total daily)
• Efficient hydrogen water preparation for multiple bottles
• Same alkaline electrolysis technology and durability as H2 Impact
• American craftsmanship with full support infrastructure
• Complete accessory compatibility for diverse applications

Many diabetes patients successfully implement maintenance protocols using HydroGenie after initial intensive phase with H2 Impact, or use HydroGenie as standalone system when twice-daily protocols fit their schedule and health goals.

Frequently Asked Questions

How long before I notice inflammatory marker improvements? Subjective improvements (energy, sleep, glucose stability) often emerge within 4-8 weeks. Objective inflammatory markers like hs-CRP typically show meaningful reductions by 3 months, with maximal benefits appearing at 6 months based on clinical trial timelines[2][4].

Can Brown’s Gas therapy replace my diabetes medications? Hydrogen therapy functions as adjunct treatment supplementing rather than replacing conventional diabetes management. Clinical trials studied hydrogen alongside standard medications, demonstrating enhanced benefits when combined. As insulin sensitivity improves, some patients reduce medication doses under medical supervision, but complete discontinuation typically isn’t appropriate[2].

Why does inflammation matter for diabetes—isn’t it just about blood sugar? Chronic inflammation directly causes insulin resistance by interfering with insulin receptor signaling through pro-inflammatory cytokines like TNF-α and IL-6. These inflammatory molecules activate inhibitory kinases that block normal insulin action, keeping glucose trapped in bloodstream. Reducing inflammation addresses root causes rather than merely managing blood sugar symptoms[9].

Is Brown’s Gas safe for long-term daily use? Extensive clinical research confirms excellent safety for sustained hydrogen therapy. The largest diabetes trial involving 1,088 patients over 6 months documented zero serious adverse events and actually lower adverse event rates compared to standard treatment alone[2]. Additional safety validation includes a study testing 72 continuous hours of hydrogen inhalation with zero clinically significant effects[26].

What makes alkaline electrolysis better than PEM for diabetes protocols? Alkaline systems offer 90,000-hour operational lifespans versus PEM’s 40,000-60,000 hours—more than double the durability for daily therapy over decades[27]. They avoid expensive platinum-group metal catalysts, provide lower operational costs, and produce true Brown’s Gas rather than artificially mixed gases. For long-term diabetes management, alkaline technology’s proven reliability and economics prove superior.

Can I use hydrogen therapy if I have other health conditions? Hydrogen demonstrates safety across diverse health conditions with minimal contraindications. However, pregnant women should consult providers before starting, patients with severe kidney disease should coordinate with nephrologists, and those with acute respiratory infections should temporarily pause inhalation (but can continue hydrogen water). The excellent safety profile and lack of drug interactions make hydrogen suitable for most complex medical situations[1].

Should I do inhalation therapy, hydrogen water, or both? Optimal results emerge from combining both approaches—inhalation provides high-concentration systemic exposure while hydrogen water maintains baseline tissue levels throughout the day. Clinical trials demonstrating greatest benefits used intensive inhalation protocols[2], while separate trials showed meaningful metabolic improvements from hydrogen water alone[19]. The combination addresses inflammation through complementary delivery routes.

Conclusion: Addressing Diabetes at Its Inflammatory Roots

Type 2 diabetes progresses through inflammatory pathways that conventional pharmaceutical approaches address incompletely—metformin, sulfonylureas, and even newer GLP-1 agonists manage blood sugar symptoms without directly targeting the chronic inflammation driving disease progression. Brown’s Gas inhalation protocols offer a fundamentally different strategy: suppress pro-inflammatory cytokines, neutralize oxidative stress triggering inflammatory cascades, enhance endogenous antioxidant defenses, and activate metabolic hormones like FGF21 that coordinate systemic inflammation resolution.

Clinical evidence spanning multiple rigorous trials establishes hydrogen therapy produces substantial anti-inflammatory effects alongside impressive metabolic improvements. The landmark study of 1,088 diabetes patients demonstrated 44% greater HOMA-IR reduction, nearly 1% HbA1c decrease, and significantly lower inflammatory burden compared to conventional treatment alone—all achieved with remarkable safety and actually fewer adverse events than standard therapy[2]. Complementary research shows similar benefits through hydrogen water consumption, with one trial demonstrating 56% CRP reduction moving patients from high cardiovascular risk to low-risk inflammatory status[4].

These documented benefits require commitment to evidence-based protocols: 2-4 hours daily hydrogen inhalation for minimum 6 months, complementary hydrogen-rich water consumption throughout the day, strategic timing optimizing anti-inflammatory windows, consistent adherence over months allowing accumulated benefits to manifest, and integration with comprehensive lifestyle strategies addressing nutrition, movement, sleep, and stress. Our H2 Impact and HydroGenie alkaline electrolysis systems provide the high-output capacity and proven durability required for sustainable long-term implementation of these clinical protocols.

For diabetes patients struggling with inadequate glycemic control despite multiple medications, experiencing inflammatory complications accelerating disease progression, or seeking to prevent prediabetes advancement through inflammation management, Brown’s Gas therapy represents a scientifically validated, remarkably safe, and practically achievable addition to comprehensive metabolic health strategies. The extensive clinical evidence, excellent safety profiles across diverse populations, and alkaline technology’s lifetime economics make consistent anti-inflammatory therapy achievable for sustainable improvements in glucose balance and long-term health outcomes.

Begin your journey toward inflammation control and improved insulin sensitivity by exploring our complete range of therapeutic hydrogen systems, reviewing our detailed usage guides, and consulting with healthcare providers experienced in integrating hydrogen therapy with conventional diabetes management. The path to better metabolic health through inflammation reduction starts with understanding the science—then implementing the proven protocols that research demonstrates work.

References

1. Ostojic SM, Korovljev D, Stajer V, Javorac D. Molecular Hydrogen Therapy—A Review on Clinical Studies and Outcomes. Molecules. 2023;28(23):7785. https://www.mdpi.com/1424-8247/16/4/541
2. Zhao Z, Ji H, Zhao Y, Liu Z, Sun R, Li Y, Ni T. Effectiveness and safety of hydrogen inhalation as an adjunct treatment in Chinese type 2 diabetes patients: A retrospective, observational, double-arm, real-life clinical study. Front Endocrinol. 2023;13:1114221. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1114221/full
3. Ji H, Zhao Z, Liu Z, Sun R, Li Y, Ding X, Ni T. Real-World Effectiveness and Safety of Hydrogen Inhalation in Chinese Patients with Type 2 Diabetes: A Single-Arm, Retrospective Study. Diabetes Metab Syndr Obes. 2023;16:2039-2050. https://www.tandfonline.com/doi/full/10.2147/DMSO.S412898
4. LeBaron TW, Singh RB, Fatima G, et al. The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial. Diabetes Metab Syndr Obes. 2020;13:889-896. https://www.dovepress.com/the-effects-of-24-week-high-concentration-hydrogen-rich-water-on-body–peer-reviewed-fulltext-article-DMSO
5. Ming Y, Ma QH, Han XL, Li HY. Molecular hydrogen improves type 2 diabetes through inhibiting oxidative stress. Exp Ther Med. 2020;20(1):359-366. https://pmc.ncbi.nlm.nih.gov/articles/PMC7291681/
6. ClinicalTrials.gov NCT05842993. Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients. https://classic.clinicaltrials.gov/ct2/show/NCT05842993
7. Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23(1):87.
8. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415-445.
9. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
10. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98-107.
11. Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI Jr. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473(24):4527-4550.
12. Song G, Li M, Sang H, et al. Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome. J Lipid Res. 2013;54(7):1884-1893.
13. Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13(6):688-694.
14. Dixon BJ, Tang J, Zhang JH. The evolution of molecular hydrogen: a noteworthy potential therapy with clinical significance. Med Gas Res. 2013;3(1):10.
15. Itoh T, Hamada N, Terazawa R, et al. Molecular hydrogen suppresses FcεRI-mediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun. 2009;389(4):651-656.
16. Kamimura N, Nishimaki K, Ohsawa I, Ohta S. Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice. Obesity. 2011;19(7):1396-1403. https://onlinelibrary.wiley.com/doi/full/10.1038/oby.2011.6
17. Okada M, Ogawa H, Takagi T, et al. A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss. Front Neurosci. 2022;16:1024634. https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.1024634/full
18. Yoritaka A, Kobayashi Y, Hayashi T, Saiki S, Hattori N. Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study. Neurol Sci. 2021;42(11):4767-4770. https://pubmed.ncbi.nlm.nih.gov/34319514/
19. Kajiyama S, Hasegawa G, Asano M, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008;28(3):137-143. https://pubmed.ncbi.nlm.nih.gov/19083400/
20. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067-2072.
21. Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol Ther. 2014;144(1):1-11.
22. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34.
23. Ishibashi T, Sato B, Rikitake M, et al. Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Med Gas Res. 2012;2(1):27.
24. Amitani H, Asakawa A, Cheng K, et al. Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle. PLoS One. 2013;8(1):e53913. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053913
25. Kawamura T, Huang CS, Tochigi N, et al. Inhaled hydrogen gas therapy for prevention of lung transplant-induced ischemia/reperfusion injury in rats. Transplantation. 2010;90(12):1344-1351.
26. Cole AR, Sperotto F, DiNardo JA, et al. Safety of Prolonged Inhalation of Hydrogen Gas in Air in Healthy Adults. Crit Care Explor. 2021;3(10):e543. https://pmc.ncbi.nlm.nih.gov/articles/PMC8505337/
27. Buttler A, Spliethoff H. Current status of water electrolysis for energy storage, grid balancing and sector coupling via power-to-gas and power-to-liquids: A review. Renew Sustain Energy Rev. 2018;82:2440-2454.